Combination therapy of human umbilical cord mesenchymal stem cells and FTY720 attenuates acute lung injury induced by lipopolysaccharide in a murine model

Oncotarget

Volumn 8, Issue 44, 2017, Pages 77407-77414

  Zhang, Zili ^a,b,d   Li, Wenfei ^c   Heng, Zhizhi ^a   Zheng, Jing ^a   Li, Puyuan ^a   Yuan, Xin ^a   Niu, Wenkai ^a   Bai, Changqing ^a   Liu, Huiying ^a  

^a Beijing 307 Hospital   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d Beijing Geriatric Hospital   (China)

Author keywords

Acute lung injury; FTY720; HUC MSCs; Lipopolysaccharide; Sphingosine 1 phosphate

Indexed keywords

CYTOKINE; FINGOLIMOD;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PNEUMONIA; SURVIVAL RATE;

EID: 85030323063     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.20491     Document Type: Article

References (23)

1. Matthay MA, Ware LB. The acute respiratory distress syndrome. N Engl J Med. 2000; 342: 1334-1349. https://doi.org/10.1056/NEJM200005043421806
2. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307: 2526-2533 https://doi.org/10.1001/jama.2012.5669
3. Pelosi P, de Abreu MG. Acute respiratory distress syndrome: we can't miss regional lung perfusion! BMC Anesthesiol. 2015; 15: 35. https://doi.org/10.1186/s12871-015-0014-z
4. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, NeffM, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353: 1685-1693. https://doi.org/10.1056/NEJMoa050333
5. Kim ES, Yun SC, Choi SJ, Jin KK, Yoo HS, Ahn SY, Dong KS, Kim SY, Ye RP, Park WS. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res. 2011; 12: 1-11. https://doi. org/10.1186/1465-9921-12-108
6. Cribbs SK, Martin GS. Stem cells in sepsis and acute lung injury. Am J Med Sci. 2011; 341: 325-332. https://doi. org/10.1097/MAJ.0b013e3181f30dee
7. Lee JW, Gupta N, Serikov V, Matthay MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther. 2009; 9: 1259-1270. https://doi. org/10.1517/14712590903213651
8. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007; 179: 1855-1863. https://doi.org/10.4049/jimmunol.179.3.1855
9. Li J, Li D, Liu X, Tang S, Wei F. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm (Lond). 2012; 9: 33. https://doi. org/10.1186/1476-9255-9-33
10. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E. Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997; 142: 208-225. https://doi.org/10.1006/taap.1996.8029
11. Mcverry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med. 2004; 170: 987-993. https://doi. org/10.1164/rccm.200405-684OC
12. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxininduced inflammatory lung injury. Am J Respir Crit Care Med. 2004; 169: 1245-1251. https://doi.org/10.1164/rccm.200309-1258OC
13. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factorinduced vascular permeability. J Biol Chem. 2003; 278: 47281-47290. https://doi.org/10.1074/jbc. M306896200
14. Natarajan V, Dudek SM, Jacobson JR, Morenovinasco L, Huang LS, Abassi T, Mathew B, Zhao Y, Wang L, Bittman R. Sphingosine-1-phosphate, FTY720, and Sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am J Respir Cell Mol Biol. 2013; 49: 6-17. https://doi.org/10.1165/rcmb.2012-0411TR
15. Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med. 2006; 355: 1124-1140. https://doi.org/10.1056/NEJMoa052643
16. Liu H, Zhang Z, Li P, Yuan X, Zheng J, Liu J, Bai C, Niu W. Regulation of S1P receptors and sphingosine kinases expression in acute pulmonary endothelial cell injury. PeerJ. 2016; 4: e2712. https://doi.org/10.7717/peerj.2712
17. Cai S, Liu A, Chen S, He H, Chen Q, Xu J, Pan C, Yang Y, Guo F, Huang Y. Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Stem Cell Res Ther. 2015; 6: 65. https://doi.org/10.1186/s13287-015-0060-y
18. Mrozek JD, Smith KM, Bing DR, Meyers PA, Simonton SC, Connett JE, Mammel MC. Exogenous surfactant and partial liquid ventilation. Am J Respir Crit Care Med. 1997; 156: 1058-1065. https://doi.org/10.1164/ajrccm.156.4.9610104
19. Liu KD, Matthay MA. Advances in critical care for the nephrologist: acute lung injury/ARDS. Clin J Am Soc Nephrol. 2008; 3: 578-586. https://doi.org/10.2215/CJN.01630407
20. Camp SM, Bittman R, Chiang ET, Moreno-Vinasco L, Mirzapoiazova T, Sammani S, Lu X, Sun C, Harbeck M, Roe M, Natarajan V, Garcia JG, Dudek SM. Synthetic analogs of FTY720 (2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol) differentially regulate pulmonary vascular permeability in vivo and in vitro. J Pharmacol Exp Ther. 2009; 331: 54-64. https://doi.org/10.1124/jpet.109.153544
21. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science. 2005; 309: 1735-1739. https://doi.org/10.1126/science.1113640
22. Blaho VA, Hla T. An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res. 2014; 55: 1596-1608. https://doi.org/10.1194/jlr. R046300
23. Müller HC, Hocke AC, Hellwig K, Gutbier B, Peters H, Schönrock SM, Tschernig T, Schmiedl A, Hippenstiel S, N'Guessan PD, Rosseau S, Suttorp N, Witzenrath M. The Sphingosine-1 phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice. Pulm Pharmacol Ther. 2011; 24: 377-385. https://doi. org/10.1016/j.pupt.2011.01.017